As the saying goes, timing is everything. This was especially true for the genetics firm, Invitae Corporation. It recently signed a direct lease for approximately 40,000 square feet at 444 De Haro St. office building in San Francisco, according to ASB Real Estate Investments (ASB).

“A medical device manufacturer had plans to vacate their lab space, creating a compelling opportunity for Invitae to occupy the premises with minimal capital expense and no downtime,” said Aaron Duncan, ASB’s senior vice president and Western region head. “The property’s combination of fully developed laboratory space and unique creative office attributes including large floorplates, open space designs and high ceilings made the building an ideal fit for Invitae, given the limited supply of this kind of product in the market.”

ASB’s ownership investment in the property is made on behalf of its Allegiance Fund, a $7.3 billion core investment vehicle.

Invitae, which also leases space from ASB at 1400 16th St. in San Francisco, has experienced rapid growth and needed to expand into additional specialized laboratory and creative office space.